Livongo Health, the diabetes management company launched last fall by former Allscripts CEO Glen Tullman, has raised $20 million in second-round funding. Kleiner Perkins Caufield & Byers (KPCB) and DFJ Venture contributed to the round, as did previous investor General Catalyst Partners.
"With thousands of people now using Livongo for Diabetes, it's clear that the best way for people to...
